Description
This option includes a provider evaluation for patients seeking compounded CJC-1295 and Ipamorelin, followed by medication shipping when deemed appropriate. These medications may be used in wellness settings and are often discussed for their potential role in growth hormone signaling and recovery support. A licensed provider reviews the patient’s medical history and questionnaire responses to determine whether treatment may be appropriate. If approved, medication is compounded and shipped directly to the patient. Treatment is not guaranteed and is subject to provider discretion.
There are no reviews yet.